Skip to main content
Erschienen in: Journal of Interventional Cardiac Electrophysiology 1/2011

01.06.2011

Personalized medicine and the genotype–phenotype dilemma

verfasst von: Dan M. Roden

Erschienen in: Journal of Interventional Cardiac Electrophysiology | Ausgabe 1/2011

Einloggen, um Zugang zu erhalten

Excerpt

Important human phenotypes like height or facial appearance run in families—that has been known for millennia. Systematic studies of the way in which crossing pea plants resulted in changes in important pea plant phenotypes such as flower color or leaf number were defined in the mid-nineteenth century by Mendel [1] and the chemical basis for “inherited inborn errors of metabolism” by Garrod [2] at the turn of the twentieth century. Thus, some of the fundamental and familiar rules that we accept in a contemporary understanding of human genetics were laid down decades ago. However, an understanding of the mechanisms whereby genetic information is transmitted from generation to generation and how this information modulates important physiologic or disease susceptibility traits has been more recent. The fundamental discovery was the double-helix structure of DNA, which immediately led to the inference that DNA replication might replicate itself [3]. The last 50 years has seen the development of increasingly robust techniques for sequencing DNA and for using DNA as a laboratory reagent. …
Literatur
1.
Zurück zum Zitat Mendel, G. (1866). Experiments in plant hybridization. Verhandlungen des naturforschenden Vereines in Brunn, bd IV fur das Jahr 1865, Abhandlungen, pp 3–47. Mendel, G. (1866). Experiments in plant hybridization. Verhandlungen des naturforschenden Vereines in Brunn, bd IV fur das Jahr 1865, Abhandlungen, pp 3–47.
2.
Zurück zum Zitat Garrod, A. E. (1923). Inborn errors of metabolism (2nd ed.). Oxford: Oxford University Press. Garrod, A. E. (1923). Inborn errors of metabolism (2nd ed.). Oxford: Oxford University Press.
3.
Zurück zum Zitat Watson, J. D., & Crick, F. H. (1953). Molecular structure of nucleic acids; a structure for deoxyribose nucleic acid. Nature, 171, 737–738.PubMedCrossRef Watson, J. D., & Crick, F. H. (1953). Molecular structure of nucleic acids; a structure for deoxyribose nucleic acid. Nature, 171, 737–738.PubMedCrossRef
4.
Zurück zum Zitat Jervell, A., & Lange-Nielsen, F. (1957). Congenital deaf-mutism, functional heart disease with prolongation of the Q-T interval and sudden death. American Heart Journal, 54, 59–68.PubMedCrossRef Jervell, A., & Lange-Nielsen, F. (1957). Congenital deaf-mutism, functional heart disease with prolongation of the Q-T interval and sudden death. American Heart Journal, 54, 59–68.PubMedCrossRef
5.
Zurück zum Zitat Romano, C., Gemme, G., & Pongiglione, R. (1963). Aritmie cardiache rare in età pediatrica. Clinical Pediatrics, 45, 656–683. Romano, C., Gemme, G., & Pongiglione, R. (1963). Aritmie cardiache rare in età pediatrica. Clinical Pediatrics, 45, 656–683.
6.
Zurück zum Zitat Ward, O. C. (1964). A new familial cardiac syndrome in children. J Irish Med Assoc, 54, 103–106. Ward, O. C. (1964). A new familial cardiac syndrome in children. J Irish Med Assoc, 54, 103–106.
7.
Zurück zum Zitat Priori, S. G., Schwartz, P. J., Napolitano, C., Bloise, R., Ronchetti, E., Grillo, M., et al. (2003). Risk stratification in the long-QT syndrome. The New England Journal of Medicine, 348, 1866–1874.PubMedCrossRef Priori, S. G., Schwartz, P. J., Napolitano, C., Bloise, R., Ronchetti, E., Grillo, M., et al. (2003). Risk stratification in the long-QT syndrome. The New England Journal of Medicine, 348, 1866–1874.PubMedCrossRef
8.
Zurück zum Zitat Priori, S. G., Napolitano, C., & Schwartz, P. J. (1999). Low penetrance in the long-QT syndrome: Clinical impact. Circulation, 99, 529–533.PubMed Priori, S. G., Napolitano, C., & Schwartz, P. J. (1999). Low penetrance in the long-QT syndrome: Clinical impact. Circulation, 99, 529–533.PubMed
9.
Zurück zum Zitat Collins, F. S., Drumm, M. L., Cole, J. L., Lockwood, W. K., Vande Woude, G. F., & Iannuzzi, M. C. (1987). Construction of a general human chromosome jumping library, with application to cystic fibrosis. Science, 235, 1046–1049.PubMedCrossRef Collins, F. S., Drumm, M. L., Cole, J. L., Lockwood, W. K., Vande Woude, G. F., & Iannuzzi, M. C. (1987). Construction of a general human chromosome jumping library, with application to cystic fibrosis. Science, 235, 1046–1049.PubMedCrossRef
10.
Zurück zum Zitat Geisterfer-Lowrance, A. A., Kass, S., Tanigawa, G., Vosberg, H. P., McKenna, W., Seidman, C. E., et al. (1990). A molecular basis for familial hypertrophic cardiomyopathy: A beta cardiac myosin heavy chain gene missense mutation. Cell, 62, 999–1006.PubMedCrossRef Geisterfer-Lowrance, A. A., Kass, S., Tanigawa, G., Vosberg, H. P., McKenna, W., Seidman, C. E., et al. (1990). A molecular basis for familial hypertrophic cardiomyopathy: A beta cardiac myosin heavy chain gene missense mutation. Cell, 62, 999–1006.PubMedCrossRef
11.
Zurück zum Zitat The International HapMap Consortium. (2005). A haplotype map of the human genome. Nature, 437, 1299–1320.CrossRef The International HapMap Consortium. (2005). A haplotype map of the human genome. Nature, 437, 1299–1320.CrossRef
12.
Zurück zum Zitat The International HapMap Consortium. (2007). A second generation human haplotype map of over 3.1 million SNPs. Nature, 449, 851–861.CrossRef The International HapMap Consortium. (2007). A second generation human haplotype map of over 3.1 million SNPs. Nature, 449, 851–861.CrossRef
13.
Zurück zum Zitat Manolio, T. A. (2010). Genomewide association studies and assessment of the risk of disease. The New England Journal of Medicine, 363, 166–176.PubMedCrossRef Manolio, T. A. (2010). Genomewide association studies and assessment of the risk of disease. The New England Journal of Medicine, 363, 166–176.PubMedCrossRef
14.
Zurück zum Zitat Milan, D. J., Lubitz, S. A., Kaab, S., & Ellinor, P. T. (2010). Genome-wide association studies in cardiac electrophysiology: Recent discoveries and implications for clinical practice. Heart Rhythm, 7, 1141–1148.PubMedCrossRef Milan, D. J., Lubitz, S. A., Kaab, S., & Ellinor, P. T. (2010). Genome-wide association studies in cardiac electrophysiology: Recent discoveries and implications for clinical practice. Heart Rhythm, 7, 1141–1148.PubMedCrossRef
15.
Zurück zum Zitat Arking, D. E., Pfeufer, A., Post, W., Kao, W. H., Newton-Cheh, C., Ikeda, M., et al. (2006). A common genetic variant in the NOS1 regulator NOS1AP modulates cardiac repolarization. Nature Genetics, 38, 644–651.PubMedCrossRef Arking, D. E., Pfeufer, A., Post, W., Kao, W. H., Newton-Cheh, C., Ikeda, M., et al. (2006). A common genetic variant in the NOS1 regulator NOS1AP modulates cardiac repolarization. Nature Genetics, 38, 644–651.PubMedCrossRef
16.
Zurück zum Zitat Pfeufer, A., Sanna, S., Arking, D. E., Muller, M., Gateva, V., Fuchsberger, C., et al. (2009). Common variants at ten loci modulate the QT interval duration in the QTSCD Study. Nature Genetics, 41, 407–414.PubMedCrossRef Pfeufer, A., Sanna, S., Arking, D. E., Muller, M., Gateva, V., Fuchsberger, C., et al. (2009). Common variants at ten loci modulate the QT interval duration in the QTSCD Study. Nature Genetics, 41, 407–414.PubMedCrossRef
17.
Zurück zum Zitat Newton-Cheh, C., Eijgelsheim, M., Rice, K. M., de Bakker, P. I. W., Yin, X., Estrada, K., et al. (2009). Common variants at ten loci influence QT interval duration in the QTGEN Study. Nature Genetics, 41, 399–406.PubMedCrossRef Newton-Cheh, C., Eijgelsheim, M., Rice, K. M., de Bakker, P. I. W., Yin, X., Estrada, K., et al. (2009). Common variants at ten loci influence QT interval duration in the QTGEN Study. Nature Genetics, 41, 399–406.PubMedCrossRef
18.
Zurück zum Zitat Kao, W. H., Arking, D. E., Post, W., Rea, T. D., Sotoodehnia, N., Prineas, R. J., et al. (2009). Genetic variations in nitric oxide synthase 1 adaptor protein are associated with sudden cardiac death in US white community-based populations. Circulation, 119, 940–951.PubMedCrossRef Kao, W. H., Arking, D. E., Post, W., Rea, T. D., Sotoodehnia, N., Prineas, R. J., et al. (2009). Genetic variations in nitric oxide synthase 1 adaptor protein are associated with sudden cardiac death in US white community-based populations. Circulation, 119, 940–951.PubMedCrossRef
19.
Zurück zum Zitat Crotti, L., Monti, M. C., Insolia, R., Peljto, A., Goosen, A., Brink, P. A., et al. (2009). NOS1AP is a genetic modifier of the long-QT syndrome. Circulation, 120, 1657–1663.PubMedCrossRef Crotti, L., Monti, M. C., Insolia, R., Peljto, A., Goosen, A., Brink, P. A., et al. (2009). NOS1AP is a genetic modifier of the long-QT syndrome. Circulation, 120, 1657–1663.PubMedCrossRef
20.
Zurück zum Zitat Tomas, M., Napolitano, C., De, G. L., Bloise, R., Subirana, I., Malovini, A., et al. (2010). Polymorphisms in the NOS1AP gene modulate QT interval duration and risk of arrhythmias in the long QT syndrome. Journal of the American College of Cardiology, 55, 2745–2752.PubMedCrossRef Tomas, M., Napolitano, C., De, G. L., Bloise, R., Subirana, I., Malovini, A., et al. (2010). Polymorphisms in the NOS1AP gene modulate QT interval duration and risk of arrhythmias in the long QT syndrome. Journal of the American College of Cardiology, 55, 2745–2752.PubMedCrossRef
21.
Zurück zum Zitat Milan, D. J., Kim, A. M., Winterfield, J. R., Jones, I. L., Pfeufer, A., Sanna, S., et al. (2009). A drug-sensitized zebrafish screen identifies multiple genes, including GINS3, as regulators of myocardial repolarization. Circulation, 120, 553–559.PubMedCrossRef Milan, D. J., Kim, A. M., Winterfield, J. R., Jones, I. L., Pfeufer, A., Sanna, S., et al. (2009). A drug-sensitized zebrafish screen identifies multiple genes, including GINS3, as regulators of myocardial repolarization. Circulation, 120, 553–559.PubMedCrossRef
22.
Zurück zum Zitat Gudbjartsson, D. F., Arnar, D. O., Helgadottir, A., Gretarsdottir, S., Holm, H., Sigurdsson, A., et al. (2007). Variants conferring risk of atrial fibrillation on chromosome 4q25. Nature, 448, 353–357.PubMedCrossRef Gudbjartsson, D. F., Arnar, D. O., Helgadottir, A., Gretarsdottir, S., Holm, H., Sigurdsson, A., et al. (2007). Variants conferring risk of atrial fibrillation on chromosome 4q25. Nature, 448, 353–357.PubMedCrossRef
23.
Zurück zum Zitat Kaab, S., Darbar, D., van Noord, C., Dupuis, J., Pfeufer, A., Newton-Cheh, C., et al. (2009). Large scale replication and meta-analysis of variants on chromosome 4q25 associated with atrial fibrillation. European Heart Journal, 30, 813–819.PubMedCrossRef Kaab, S., Darbar, D., van Noord, C., Dupuis, J., Pfeufer, A., Newton-Cheh, C., et al. (2009). Large scale replication and meta-analysis of variants on chromosome 4q25 associated with atrial fibrillation. European Heart Journal, 30, 813–819.PubMedCrossRef
24.
Zurück zum Zitat Mommersteeg, M. T. M., Brown, N. A., Prall, O. W. J., de Gier-de Vries, C., Harvey, R. P., Moorman, A. F. M., et al. (2007). Pitx2c and Nkx2-5 are required for the formation and identity of the pulmonary myocardium. Circulation Research, 101, 902–909.PubMedCrossRef Mommersteeg, M. T. M., Brown, N. A., Prall, O. W. J., de Gier-de Vries, C., Harvey, R. P., Moorman, A. F. M., et al. (2007). Pitx2c and Nkx2-5 are required for the formation and identity of the pulmonary myocardium. Circulation Research, 101, 902–909.PubMedCrossRef
25.
Zurück zum Zitat Wang, J., Klysik, E., Sood, S., Johnson, R. L., Wehrens, X. H., & Martin, J. F. (2010). Pitx2 prevents susceptibility to atrial arrhythmias by inhibiting left-sided pacemaker specification. Proceedings of the National Academy of Sciences of the United States of America, 107, 9753–9758.PubMedCrossRef Wang, J., Klysik, E., Sood, S., Johnson, R. L., Wehrens, X. H., & Martin, J. F. (2010). Pitx2 prevents susceptibility to atrial arrhythmias by inhibiting left-sided pacemaker specification. Proceedings of the National Academy of Sciences of the United States of America, 107, 9753–9758.PubMedCrossRef
26.
Zurück zum Zitat Gudbjartsson, D. F., Holm, H., Gretarsdottir, S., Thorleifsson, G., Walters, G. B., Thorgeirsson, G., et al. (2009). A sequence variant in ZFHX3 on 16q22 associates with atrial fibrillation and ischemic stroke. Nature Genetics, 41, 876–878.PubMedCrossRef Gudbjartsson, D. F., Holm, H., Gretarsdottir, S., Thorleifsson, G., Walters, G. B., Thorgeirsson, G., et al. (2009). A sequence variant in ZFHX3 on 16q22 associates with atrial fibrillation and ischemic stroke. Nature Genetics, 41, 876–878.PubMedCrossRef
27.
Zurück zum Zitat Ellinor, P. T., Lunetta, K. L., Glazer, N. L., Pfeufer, A., Alonso, A., Chung, M. K., et al. (2010). Common variants in KCNN3 are associated with lone atrial fibrillation. Nature Genetics, 42, 240–244.PubMedCrossRef Ellinor, P. T., Lunetta, K. L., Glazer, N. L., Pfeufer, A., Alonso, A., Chung, M. K., et al. (2010). Common variants in KCNN3 are associated with lone atrial fibrillation. Nature Genetics, 42, 240–244.PubMedCrossRef
28.
Zurück zum Zitat Body, S. C., Collard, C. D., Shernan, S. K., Fox, A. A., Liu, K. Y., Ritchie, M. D., et al. (2009). Variation in the 4q25 chromosomal locus predicts atrial fibrillation after coronary artery bypass graft surgery. Circ Cardiovasc Genet, 2, 499–506.PubMedCrossRef Body, S. C., Collard, C. D., Shernan, S. K., Fox, A. A., Liu, K. Y., Ritchie, M. D., et al. (2009). Variation in the 4q25 chromosomal locus predicts atrial fibrillation after coronary artery bypass graft surgery. Circ Cardiovasc Genet, 2, 499–506.PubMedCrossRef
29.
Zurück zum Zitat Husser, D., Adams, V., Piorkowski, C., Hindricks, G., & Bollmann, A. (2010). Chromosome 4q25 variants and atrial fibrillation recurrence after catheter ablation. Journal of the American College of Cardiology, 55, 747–753.PubMedCrossRef Husser, D., Adams, V., Piorkowski, C., Hindricks, G., & Bollmann, A. (2010). Chromosome 4q25 variants and atrial fibrillation recurrence after catheter ablation. Journal of the American College of Cardiology, 55, 747–753.PubMedCrossRef
30.
Zurück zum Zitat Rowan, S. B., Estrada, J. C., Stubblefield, T., Kucera, G., Carter, S., Roden, D. M., et al. (2009). A single nucleotide polymorphism at 4q25 associated with atrial fibrillation modulates symptomatic response to antiarrhythmic drug therapy. Heart Rhythm, 6, PO04-7. Rowan, S. B., Estrada, J. C., Stubblefield, T., Kucera, G., Carter, S., Roden, D. M., et al. (2009). A single nucleotide polymorphism at 4q25 associated with atrial fibrillation modulates symptomatic response to antiarrhythmic drug therapy. Heart Rhythm, 6, PO04-7.
31.
Zurück zum Zitat Gretarsdottir, S., Thorleifsson, G., Manolescu, A., Styrkarsdottir, U., Helgadottir, A., Gschwendtner, A., et al. (2008). Risk variants for atrial fibrillation on chromosome 4q25 associate with ischemic stroke. Annals of Neurology, 64, 402–409.PubMedCrossRef Gretarsdottir, S., Thorleifsson, G., Manolescu, A., Styrkarsdottir, U., Helgadottir, A., Gschwendtner, A., et al. (2008). Risk variants for atrial fibrillation on chromosome 4q25 associate with ischemic stroke. Annals of Neurology, 64, 402–409.PubMedCrossRef
32.
Zurück zum Zitat Lubitz, S. A., Sinner, M. F., Lunetta, K. L., Makino, S., Pfeufer, A., Rahman, R., et al. (2010). Independent susceptibility markers for atrial fibrillation on chromosome 4q25. Circulation, 122, 976–984.PubMedCrossRef Lubitz, S. A., Sinner, M. F., Lunetta, K. L., Makino, S., Pfeufer, A., Rahman, R., et al. (2010). Independent susceptibility markers for atrial fibrillation on chromosome 4q25. Circulation, 122, 976–984.PubMedCrossRef
33.
Zurück zum Zitat Bezzina, C. R., Pazoki, R., Bardai, A., Marsman, R. F., de Jong, J. S., Blom, M. T., et al. (2010). Genome-wide association study identifies a susceptibility locus at 21q21 for ventricular fibrillation in acute myocardial infarction. Nature Genetics, 42, 688–691.PubMedCrossRef Bezzina, C. R., Pazoki, R., Bardai, A., Marsman, R. F., de Jong, J. S., Blom, M. T., et al. (2010). Genome-wide association study identifies a susceptibility locus at 21q21 for ventricular fibrillation in acute myocardial infarction. Nature Genetics, 42, 688–691.PubMedCrossRef
34.
Zurück zum Zitat Holm, H., Gudbjartsson, D. F., Arnar, D. O., Thorleifsson, G., Thorgeirsson, G., Stefansdottir, H., et al. (2010). Several common variants modulate heart rate, PR interval and QRS duration. Nature Genetics, 42, 117–122.PubMedCrossRef Holm, H., Gudbjartsson, D. F., Arnar, D. O., Thorleifsson, G., Thorgeirsson, G., Stefansdottir, H., et al. (2010). Several common variants modulate heart rate, PR interval and QRS duration. Nature Genetics, 42, 117–122.PubMedCrossRef
35.
Zurück zum Zitat Chambers, J. C., Zhao, J., Terracciano, C. M. N., Bezzina, C. R., Zhang, W., Kaba, R., et al. (2010). Genetic variation in SCN10A influences cardiac conduction. Nature Genetics, 42, 149–152.PubMedCrossRef Chambers, J. C., Zhao, J., Terracciano, C. M. N., Bezzina, C. R., Zhang, W., Kaba, R., et al. (2010). Genetic variation in SCN10A influences cardiac conduction. Nature Genetics, 42, 149–152.PubMedCrossRef
36.
Zurück zum Zitat Pfeufer, A., van Noord, C., Marciante, K. D., Arking, D. E., Larson, M. G., Smith, A. V., et al. (2010). Genome-wide association study of PR interval. Nature Genetics, 42, 153–159.PubMedCrossRef Pfeufer, A., van Noord, C., Marciante, K. D., Arking, D. E., Larson, M. G., Smith, A. V., et al. (2010). Genome-wide association study of PR interval. Nature Genetics, 42, 153–159.PubMedCrossRef
37.
Zurück zum Zitat Denny, J. C., Ritchie, M. D., Crawford, D. C., Schildcrout, J. S., Ramirez, A. H., Pulley, J. M., et al. (2010). Identification of genomic predictors of atrioventricular conduction: Using electronic medical records as a tool for genome science. Circulation, 122, 2016–2021.PubMedCrossRef Denny, J. C., Ritchie, M. D., Crawford, D. C., Schildcrout, J. S., Ramirez, A. H., Pulley, J. M., et al. (2010). Identification of genomic predictors of atrioventricular conduction: Using electronic medical records as a tool for genome science. Circulation, 122, 2016–2021.PubMedCrossRef
38.
Zurück zum Zitat Sotoodehnia, N., Isaacs, A., de Bakker, P. I., Dorr, M., Newton-Cheh, C., Nolte, I. M., et al. (2010). Common variants in 22 loci are associated with QRS duration and cardiac ventricular conduction. Nature Genetics, 42, 1068–1076.PubMedCrossRef Sotoodehnia, N., Isaacs, A., de Bakker, P. I., Dorr, M., Newton-Cheh, C., Nolte, I. M., et al. (2010). Common variants in 22 loci are associated with QRS duration and cardiac ventricular conduction. Nature Genetics, 42, 1068–1076.PubMedCrossRef
39.
Zurück zum Zitat Manolio, T. A., Collins, F. S., Cox, N. J., Goldstein, D. B., Hindorff, L. A., Hunter, D. J., et al. (2009). Finding the missing heritability of complex diseases. Nature, 461, 747–753.PubMedCrossRef Manolio, T. A., Collins, F. S., Cox, N. J., Goldstein, D. B., Hindorff, L. A., Hunter, D. J., et al. (2009). Finding the missing heritability of complex diseases. Nature, 461, 747–753.PubMedCrossRef
40.
Zurück zum Zitat Shuldiner, A. R., O'Connell, J. R., Bliden, K. P., Gandhi, A., Ryan, K., Horenstein, R. B., et al. (2009). Association of cytochrome P450 2C19 genotype with the antiplatelet effect and clinical efficacy of clopidogrel therapy. Journal of the American Medical Association, 302, 849–857.PubMedCrossRef Shuldiner, A. R., O'Connell, J. R., Bliden, K. P., Gandhi, A., Ryan, K., Horenstein, R. B., et al. (2009). Association of cytochrome P450 2C19 genotype with the antiplatelet effect and clinical efficacy of clopidogrel therapy. Journal of the American Medical Association, 302, 849–857.PubMedCrossRef
41.
Zurück zum Zitat Veenstra, D. L., You, J. H., Rieder, M. J., Farin, F. M., Wilkerson, H. W., Blough, D. K., et al. (2005). Association of vitamin K epoxide reductase complex 1 (VKORC1) variants with warfarin dose in a Hong Kong Chinese patient population. Pharmacogenetics and Genomics, 15, 687–691.PubMedCrossRef Veenstra, D. L., You, J. H., Rieder, M. J., Farin, F. M., Wilkerson, H. W., Blough, D. K., et al. (2005). Association of vitamin K epoxide reductase complex 1 (VKORC1) variants with warfarin dose in a Hong Kong Chinese patient population. Pharmacogenetics and Genomics, 15, 687–691.PubMedCrossRef
42.
Zurück zum Zitat Cooper, G. M., Johnson, J. A., Langaee, T. Y., Feng, H., Stanaway, I. B., Schwarz, U. I., et al. (2008). A genome-wide scan for common genetic variants with a large influence on warfarin maintenance dose. Blood, 112, 1022–1027.PubMedCrossRef Cooper, G. M., Johnson, J. A., Langaee, T. Y., Feng, H., Stanaway, I. B., Schwarz, U. I., et al. (2008). A genome-wide scan for common genetic variants with a large influence on warfarin maintenance dose. Blood, 112, 1022–1027.PubMedCrossRef
43.
Zurück zum Zitat Takeuchi, F., McGinnis, R., Bourgeois, S., Barnes, C., Eriksson, N., Soranzo, N., et al. (2009). A genome-wide association study confirms VKORC1, CYP2C9, and CYP4F2 as principal genetic determinants of warfarin dose. PLoS Genetics, 5, e1000433.PubMedCrossRef Takeuchi, F., McGinnis, R., Bourgeois, S., Barnes, C., Eriksson, N., Soranzo, N., et al. (2009). A genome-wide association study confirms VKORC1, CYP2C9, and CYP4F2 as principal genetic determinants of warfarin dose. PLoS Genetics, 5, e1000433.PubMedCrossRef
44.
Zurück zum Zitat Roden, D. M., & Brown, N. J. (2001). Preprescription genotyping: not yet ready for prime time, but getting there. Circulation, 103, 1608–1610.PubMed Roden, D. M., & Brown, N. J. (2001). Preprescription genotyping: not yet ready for prime time, but getting there. Circulation, 103, 1608–1610.PubMed
45.
Zurück zum Zitat Collins, F. (2009). Opportunities and challenges for the NIH—an interview with Francis Collins. Interview by Robert Steinbrook. The New England Journal of Medicine, 361, 1321–1323.PubMedCrossRef Collins, F. (2009). Opportunities and challenges for the NIH—an interview with Francis Collins. Interview by Robert Steinbrook. The New England Journal of Medicine, 361, 1321–1323.PubMedCrossRef
46.
Zurück zum Zitat Pepe, M. S., Janes, H., Longton, G., Leisenring, W., & Newcomb, P. (2004). Limitations of the odds ratio in gauging the performance of a diagnostic, prognostic, or screening marker. American Journal of Epidemiology, 159, 882–890.PubMedCrossRef Pepe, M. S., Janes, H., Longton, G., Leisenring, W., & Newcomb, P. (2004). Limitations of the odds ratio in gauging the performance of a diagnostic, prognostic, or screening marker. American Journal of Epidemiology, 159, 882–890.PubMedCrossRef
47.
Zurück zum Zitat Darbar, D., Herron, K. J., Ballew, J. D., Jahangir, A., Gersh, B. J., Shen, W. K., et al. (2003). Familial atrial fibrillation is a genetically heterogeneous disorder. Journal of the American College of Cardiology, 41, 2185–2192.PubMedCrossRef Darbar, D., Herron, K. J., Ballew, J. D., Jahangir, A., Gersh, B. J., Shen, W. K., et al. (2003). Familial atrial fibrillation is a genetically heterogeneous disorder. Journal of the American College of Cardiology, 41, 2185–2192.PubMedCrossRef
48.
Zurück zum Zitat Ellinor, P. T., Yoerger, D. M., Ruskin, J. N., & Macrae, C. A. (2005). Familial aggregation in lone atrial fibrillation. Human Genetics, 118, 179–184.PubMedCrossRef Ellinor, P. T., Yoerger, D. M., Ruskin, J. N., & Macrae, C. A. (2005). Familial aggregation in lone atrial fibrillation. Human Genetics, 118, 179–184.PubMedCrossRef
49.
Zurück zum Zitat Friedlander, Y., Siscovick, D. S., Weinmann, S., Austin, M. A., Psaty, B. M., Lemaitre, R. N., et al. (1998). Family history as a risk factor for primary cardiac arrest. Circulation, 97, 155–160.PubMed Friedlander, Y., Siscovick, D. S., Weinmann, S., Austin, M. A., Psaty, B. M., Lemaitre, R. N., et al. (1998). Family history as a risk factor for primary cardiac arrest. Circulation, 97, 155–160.PubMed
50.
Zurück zum Zitat Jouven, X., Desnos, M., Guerot, C., & Ducimetiere, P. (1999). Predicting sudden death in the population: The Paris Prospective Study I. Circulation, 99, 1978–1983.PubMed Jouven, X., Desnos, M., Guerot, C., & Ducimetiere, P. (1999). Predicting sudden death in the population: The Paris Prospective Study I. Circulation, 99, 1978–1983.PubMed
51.
Zurück zum Zitat Dekker, L. R. C., Bezzina, C. R., Henriques, J. P. S., Tanck, M. W., Koch, K. T., Alings, M. W., et al. (2006). Familial sudden death is an important risk factor for primary ventricular fibrillation: A case–control study in acute myocardial infarction patients. Circulation, 114, 1140–1145.PubMedCrossRef Dekker, L. R. C., Bezzina, C. R., Henriques, J. P. S., Tanck, M. W., Koch, K. T., Alings, M. W., et al. (2006). Familial sudden death is an important risk factor for primary ventricular fibrillation: A case–control study in acute myocardial infarction patients. Circulation, 114, 1140–1145.PubMedCrossRef
52.
Zurück zum Zitat Ng, S. B., Turner, E. H., Robertson, P. D., Flygare, S. D., Bigham, A. W., Lee, C., et al. (2009). Targeted capture and massively parallel sequencing of 12 human exomes. Nature, 461, 272–276.PubMedCrossRef Ng, S. B., Turner, E. H., Robertson, P. D., Flygare, S. D., Bigham, A. W., Lee, C., et al. (2009). Targeted capture and massively parallel sequencing of 12 human exomes. Nature, 461, 272–276.PubMedCrossRef
53.
Zurück zum Zitat Choi, M., Scholl, U. I., Ji, W., Liu, T., Tikhonova, I. R., Zumbo, P., et al. (2009). Genetic diagnosis by whole exome capture and massively parallel DNA sequencing. Proceedings of the National Academy of Sciences of the United States of America, 106, 19096–19101.PubMedCrossRef Choi, M., Scholl, U. I., Ji, W., Liu, T., Tikhonova, I. R., Zumbo, P., et al. (2009). Genetic diagnosis by whole exome capture and massively parallel DNA sequencing. Proceedings of the National Academy of Sciences of the United States of America, 106, 19096–19101.PubMedCrossRef
54.
Zurück zum Zitat Lupski, J. R., Reid, J. G., Gonzaga-Jauregui, C., Rio, D. D., Chen, D. C., Nazareth, L., et al. (2010). Whole-genome sequencing in a patient with Charcot–Marie–Tooth neuropathy. The New England Journal of Medicine, 362, 1181–1191.PubMedCrossRef Lupski, J. R., Reid, J. G., Gonzaga-Jauregui, C., Rio, D. D., Chen, D. C., Nazareth, L., et al. (2010). Whole-genome sequencing in a patient with Charcot–Marie–Tooth neuropathy. The New England Journal of Medicine, 362, 1181–1191.PubMedCrossRef
55.
Zurück zum Zitat Ashley, E. A., Butte, A. J., Wheeler, M. T., Chen, R., Klein, T. E., Dewey, F. E., et al. (2010). Clinical assessment incorporating a personal genome. Lancet, 375, 1525–1535.PubMedCrossRef Ashley, E. A., Butte, A. J., Wheeler, M. T., Chen, R., Klein, T. E., Dewey, F. E., et al. (2010). Clinical assessment incorporating a personal genome. Lancet, 375, 1525–1535.PubMedCrossRef
56.
Zurück zum Zitat Kohane, I. S., Masys, D. R., & Altman, R. B. (2006). The incidentalome: A threat to genomic medicine. Journal of the American Medical Association, 296, 212–215.PubMedCrossRef Kohane, I. S., Masys, D. R., & Altman, R. B. (2006). The incidentalome: A threat to genomic medicine. Journal of the American Medical Association, 296, 212–215.PubMedCrossRef
Metadaten
Titel
Personalized medicine and the genotype–phenotype dilemma
verfasst von
Dan M. Roden
Publikationsdatum
01.06.2011
Verlag
Springer US
Erschienen in
Journal of Interventional Cardiac Electrophysiology / Ausgabe 1/2011
Print ISSN: 1383-875X
Elektronische ISSN: 1572-8595
DOI
https://doi.org/10.1007/s10840-011-9561-5

Weitere Artikel der Ausgabe 1/2011

Journal of Interventional Cardiac Electrophysiology 1/2011 Zur Ausgabe

Screening-Mammografie offenbart erhöhtes Herz-Kreislauf-Risiko

26.04.2024 Mammografie Nachrichten

Routinemäßige Mammografien helfen, Brustkrebs frühzeitig zu erkennen. Anhand der Röntgenuntersuchung lassen sich aber auch kardiovaskuläre Risikopatientinnen identifizieren. Als zuverlässiger Anhaltspunkt gilt die Verkalkung der Brustarterien.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Adipositas-Medikament auch gegen Schlafapnoe wirksam

24.04.2024 Adipositas Nachrichten

Der als Antidiabetikum sowie zum Gewichtsmanagement zugelassene Wirkstoff Tirzepatid hat in Studien bei adipösen Patienten auch schlafbezogene Atmungsstörungen deutlich reduziert, informiert der Hersteller in einer Vorab-Meldung zum Studienausgang.

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.